Literature DB >> 8383963

Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation.

M Okamoto1, T Hayashi, S Kono, G Inoue, M Kubota, M Okamoto1, H Kuzuya, H Imura.   

Abstract

We investigated whether phosphatidylinositol 3-kinase (PI3K) is phosphorylated and whether its specific activity is increased by insulin stimulation in vivo using Fao cells and antibodies raised against the 85 kDa subunit of PI3K, insulin-receptor substrate-1 (IRS-1), and phosphotyrosine (pTyr). PI3K activity was detected in the immunoprecipitate produced with anti-PI3K at a basal state. The activity was increased 2-3-fold by insulin stimulation, although the protein concentration of kinase in the anti-PI3K immunoprecipitates was the same before and after insulin stimulation. Both anti-pTyr and anti-IRS-1 antibodies immunoprecipitated the kinase activity only after insulin stimulation. After the first immunoprecipitation with anti-pTyr, the supernatant was immunoprecipitated once more with anti-PI3K. PI3K activity in the second immunoprecipitate revealed little difference between the basal and insulin-stimulated states, suggesting that most of the insulin-activated portion of PI3K was precipitated by anti-pTyr. Both IRS-1 and the insulin-receptor beta-subunit (95 kDa) were phosphorylated on tyrosine residues by insulin stimulation and immunoprecipitated with anti-pTyr. However, phosphorylation of neither subunit of PI3K (85 kDa or 110 kDa) was detectable in the immunoprecipitate produced with anti-pTyr. The 185 kDa pTyr-containing protein was immunoprecipitated with anti-PI3K after insulin stimulation, although there was little phosphorylation of the 85 kDa protein. pTyr in the 110 kDa protein immunoprecipitated with anti-PI3K was below detectable levels. These results indicate that the specific activity of PI3K is increased by insulin stimulation without detectable tyrosine phosphorylation of PI3K itself in Fao cells. The majority of the insulin-activated portion of PI3K is associated with pTyr-containing proteins including IRS-1, which suggests that this is important for activation of PI3K by insulin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383963      PMCID: PMC1132276          DOI: 10.1042/bj2900327

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Preparation and use of anti-phosphotyrosine antibodies to study structure and function of insulin receptor.

Authors:  M F White; J M Backer
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.

Authors:  X J Sun; P Rothenberg; C R Kahn; J M Backer; E Araki; P A Wilden; D A Cahill; B J Goldstein; M F White
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

3.  cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor.

Authors:  J A Escobedo; S Navankasattusas; W M Kavanaugh; D Milfay; V A Fried; L T Williams
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

4.  Phosphorylation in vitro of the 85 kDa subunit of phosphatidylinositol 3-kinase and its possible activation by insulin receptor tyrosine kinase.

Authors:  H Hayashi; N Miyake; F Kanai; F Shibasaki; T Takenawa; Y Ebina
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

5.  Prediction of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

6.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

Authors:  E Y Skolnik; B Margolis; M Mohammadi; E Lowenstein; R Fischer; A Drepps; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

7.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors.

Authors:  P Hu; B Margolis; E Y Skolnik; R Lammers; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  In vitro association of phosphatidylinositol 3-kinase activity with the activated insulin receptor tyrosine kinase.

Authors:  K Yonezawa; K Yokono; K Shii; W Ogawa; A Ando; K Hara; S Baba; Y Kaburagi; R Yamamoto-Honda; K Momomura
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

10.  Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor.

Authors:  M Kasuga; F A Karlsson; C R Kahn
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

View more
  4 in total

1.  Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.

Authors:  M Kobayashi; S Nagata; T Iwasaki; K Yanagihara; I Saitoh; Y Karouji; S Ihara; Y Fukui
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield.

Authors:  Peter Halasz; Gavan Holloway; Stephen J Turner; Barbara S Coulson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

3.  Estrogen sulfotransferase inhibits adipocyte differentiation.

Authors:  Taira Wada; Chibueze A Ihunnah; Jie Gao; Xiaojuan Chai; Su Zeng; Brian J Philips; J Peter Rubin; Kacey G Marra; Wen Xie
Journal:  Mol Endocrinol       Date:  2011-08-04

4.  Insulin-induced activation of phosphoinositide 3-kinase in Fao cells.

Authors:  T Hayashi; M Okamoto; Y Yoshimasa; G Inoue; K Yamada; S Kono; M Shigemoto; J Suga; H Kuzuya; K Nakao
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.